Moreover, numerous evidence explains that ageing patients with complex meniscus tears in the context of degenerative arthritis should not go through arthroscopic surgery. The patients who are healthy, young and have tears close to the more vascular periphery of the meniscus, the direct meniscus repair is the option, but it is not suitable for all the patients. The orthobiologics; mesenchymal stem cells or platelet-rich plasma presents promising outcomes as standalone treatments or in augmenting surgical repairs. However, more investigation is demanded to estimate the role of orthobiologics in meniscal tear management.